Skip to main content
TipRanks
Go Ultimate75% OFF

a2 Milk Company (A2M) Q4 2026 Earnings Report

188 Followers

AU:A2M Q4 2026 EPS Results

Actual EPS
AUD 0.11
Consensus EPS
AUD 0.11
Beat/Miss
Beat by +AUD 0.00
One Year Ago EPS
AUD 0.13

AU:A2M Q4 2026 Revenue Results

Actual Revenue
AUD 806.88M
Expected Revenue
AUD 800.44M
Beat/Miss
Beat by +AUD 6.44M
YoY Revenue Growth
-2.66%

Earnings Announcement Details

Quarter
Q4 2026
Date
08/16/2026
Time
After Close
Conference Call
Sunday, August 16, 2026
AU:A2M Upcoming Earnings

a2 Milk Company's next earnings date is estimated for February 22, 2027, based on past reporting schedules.

Q4 2026 Earnings Call Audio

AU:A2M Q4 2026 Earnings Call
0:00 / 0:00

Q4 2026 Earnings Slide Deck

Q4 2026 Earnings Call Summary

Q4 2026
Earnings Call Date:Aug 16, 2026|% Change Since:―|
Earnings Call Sentiment|Neutral

The call presented a mixed picture: the company delivered strong top-line growth (+12.4%), solid underlying EBITDA and multiple growth vectors (U.S., ANZ, other nutritionals, innovation), completed strategic supply-chain moves (a2 Pokeno) and returned significant capital to shareholders. However, a material fourth-quarter supply-chain disruption severely impacted China label IMF sales and in-market availability, pressured reported margins and required elevated marketing and recovery spend. Management outlined a clear recovery plan and expects FY'27 growth weighted to the second half, but near-term margin and sales phasing remain challenged.

Company Guidance

The company guided FY27 to mid‑single‑digit revenue growth with first‑half revenue broadly in line with FY26 and group revenue and EBITDA materially weighted to the second half; it expects EBITDA margin of approximately 15% (versus FY25 EBITDA margin of 16.6% and FY26 underlying margin of 15.6%), with most of the ~1.6 percentage‑point year‑on‑year decline driven by gross‑margin headwinds (mix dilution as IMF is broadly flat while liquid milk and other nutritionals grow, plus higher milk/ingredient COGS) and a higher marketing reinvestment profile (phased into H1, roughly ~2 percentage points higher reinvestment in H1), IMF sales to be impacted by Q4 supply‑chain flow‑on effects with a gradual recovery over the year supported by increased marketing, and a2 Pokeno expected to reach EBITDA breakeven in FY27.

  • Revenue GrowthGroup revenue increased 12.4% year-on-year to approximately $1.97 billion (FY'26), driven by broad-based growth across geographies and product categories.
  • Underlying EBITDA and Earnings ImprovementUnderlying EBITDA (excluding a2 Pokeno) rose 5.4% to $307.6 million with an underlying EBITDA margin of 15.6%. Underlying net profit after tax and underlying EPS increased by ~7%.
  • Strong Regional Performance — U.S. and ANZU.S. net sales revenue grew ~29% to $179 million and achieved EBITDA breakeven in H2 for the first time. ANZ delivered double-digit revenue growth (Australia liquid milk revenue up 17% to $245 million) and gained retail shares (overall share to 11.7%; lactose-free share to 22.6%).
  • Category Strength — Other Nutritionals and Liquid MilkOther nutritionals delivered substantial growth (cited as +42% excluding a2 Pokeno; separately noted nearly 60% to $216 million led by kids and seniors products). Liquid milk grew strongly (~22% quoted) and outperformed markets.
  • Innovation Contribution and Product PipelineNew product launches accounted for more than 50% of FY'26 sales growth. Product portfolio expanded from 8 categories/markets in FY'21 to a planned 36 by end-FY'27; further launches and formulation upgrades (a2 Platinum and a2 Genesis) planned in FY'27.
  • Supply Chain Transformation — a2 Pokeno AcquisitionCompleted acquisition of a2 Pokeno, commenced capital upgrades on time and on budget, doubled the Pokeno team, secured China label registration amendments; site on track for EBITDA breakeven in FY'27 and will in-source a2 Platinum to capture vertical margin.
  • Capital Management and DividendsDeclared total ordinary and special dividends of $453 million for FY'26, including a $300 million special dividend and an increased ordinary dividend (final dividend $0.095 per share; payout ratio ~74%).
  • Strong Balance Sheet and LiquidityClosing cash and term deposits of $784.5 million, no external debt and a balance sheet positioned to support growth and supply chain investment.

AU:A2M Earnings History

AU:A2M earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 22, 20272027 (Q2)0.11-0.14――
Aug 16, 20262026 (Q4)0.110.110.13-14.38% (-0.02)
Feb 15, 20262026 (Q2)0.120.140.133.07% (+0.03)
Aug 17, 20252025 (Q4)0.120.130.0934.21% (+0.03)
Feb 16, 20252025 (Q2)0.090.100.17.63% (+0.01)
Aug 18, 20242024 (Q4)0.100.090.090.88% (+0.00)
Feb 18, 20242024 (Q2)0.080.100.0819.19% (+0.02)
Aug 20, 20232023 (Q4)0.080.090.0732.94% (+0.02)
Feb 19, 20232023 (Q2)0.080.080.0723.75% (+0.02)
Aug 28, 20222022 (Q4)0.090.07-0.04293.18% (+0.11)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed